[1]张梅香,王娟,刘珍珍,等.过氧化物酶抗体及其干预措施对妊娠早期自身免疫性甲状腺疾病孕妇妊娠结局的影响[J].中国计划生育和妇产科,2019,(10):57-60,63.
　ZHANG Mei-xiang,WANG Juan,LIU Zhen-zhen,et al.The effects of peroxidase antibody and supplementation of levothyroxine on pregnancy outcomes in pregnant women with autoimmune thyroid disease[J].Chinese Journal of Family Planning & Gynecotokology,2019,(10):57-60,63.
点击复制

过氧化物酶抗体及其干预措施对妊娠早期自身免疫性甲状腺疾病孕妇妊娠结局的影响
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2019年10期
页码:
57-60,63
栏目:
论著与临床
出版日期:
2019-10-25

文章信息/Info

Title:
The effects of peroxidase antibody and supplementation of levothyroxine on pregnancy outcomes in pregnant women with autoimmune thyroid disease
作者:
张梅香; 王娟; 刘珍珍; 沈晓华; 庞元鑫; 柳正清*
苏州市第九人民医院（原吴江区第一人民医院）内分泌科
Author(s):
ZHANG Mei-xiang; WANG Juan; LIU Zhen-zhen; SHEN Xiao-hua; PANG Yuan-xin;  LIU Zheng-qing*
Department of Endocrinology, the First People's Hospital of Wujiang District, Suzhou Jiangsu 215200, P.R.China
关键词:
妊娠期; 甲状腺过氧化物酶抗体; 甲状腺素; 妊娠结局
Keywords:
pregnancy; thyroid peroxidase antibody;  thyroxine;  pregnancy outcome;  perinatal infant
分类号:
R 7142
摘要:
目的评估过氧化物酶抗体阳性但无明显甲状腺功能障碍的孕妇妊娠结局，并探索左旋甲状腺素（levothyroxine, L-T4）治疗对妊娠结局及围产儿的影响。 方法选取2015年1月至2017年1月在苏州市第九人民医院（原吴江区第一人民院）诊断并分娩的131例单纯甲状腺过氧化物酶抗体（thyroid peroxidase antibody, TPOAb）阳性孕妇，根据患者就诊顺序随机分为A组和B组， A组给予L-T4治疗（66例），B组未予L-T4治疗（65例）。同时采用等距随机抽样方法选取同期在我院产检并分
Abstract:
ObjectiveTo assess the pregnancy outcome of pregnant women with positive peroxidase antibodies but no significant thyroid dysfunction, and to explore the effects of levothyroxine(L-T4) treatment on pregnancy outcomes and perinatal infants. MethodsFrom J

参考文献/References:

［1］Korevaar TIM, Medici M, Visser TJ, et al. Thyroid disease in pregnancy:new insights in diagnosis and clinical management ［J］. Nature Reviews Endocrinology，2017，13 (10):610-622. ［2］HOU Jiatong, YU Ping, ZHU Huijuan, et al. The impact of maternal hypothyroidism during pregnancy on neonatal outcomes: a systematic review and meta-analysis ［J］. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology, 2016, 32 (1): 9-13. ［3］MARAKA S, OSPINA N M, O'KEEFFE D T, et al. Subclinical hypothyroidism in pregnancy: a systematic review and meta-analysis ［J］. Thyroid : Official Journal of the American Thyroid Association, 2016, 26 (4): 580-590. ［4］刘正云，张克勤．甲状腺过氧化物酶抗体阳性孕妇妊娠结局的初步研究 ［J］．中华内分泌代谢杂志，2015，31（12）：1041-1045． ［5］THANGARATINAM S, TAN A, KNOX E, et al. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence ［J］. BMJ (Clinical Research ed.), 2011, 342 (1): d 2616. ［6］KOREVAAR T I, SCHALEKAMP-TIMMERMANS S, DE RIJKE Y B, et al. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the Generation R study ［J］. The Journal of Clinical Endocrinology and Metabolism, 2013, 98 (11): 4382-4390. ［7］LATA K, DUTTA P, SRIDHAR S, et al. Thyroid autoimmunity and obstetric outcomes in women with recurrent miscarriage: a case-control study ［J］. Endocrine Connections, 2013, 2 (2): 118-124. ［8］NEGRO R, FORMOSO G, MANGIERI T, et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications ［J］. The Journal of Clinical Endocrinology and Metabolism, 2006, 91 (7): 2587-2591. ［9］SHEEHAN P M, NANKERVIS A, ARAUJO JNIOR E, et al. Maternal thyroid disease and preterm birth: systematic review and Meta-Analysis ［J］. The Journal of Clinical Endocrinology and Metabolism, 2015, 100 (11): 4325-4331. ［10］KARAKOSTA P, ALEGAKIS D, GEORGIOU V A, et al. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes ［J］. Journal of Clinical Endocrinology & Metabolism, 2012, 97 (12): 4464-4472. ［11］KUMRU P, ERDOGDU E, ARISOY R, et al. Effect of thyroid dysfunction and autoimmunity on pregnancy outcomes in low risk population ［J］. Archives of Gynecology and Obstetrics, 2015, 291 (5): 1047-1054. ［12］SAKI F, DABBAGHMANESH M H, GHAEMI S Z, et al. Thyroid autoimmunity in pregnancy and its influences on maternal and fetal outcome in Iran (a prospective study) ［J］. Endocrine Research, 2015, 40 (3): 139-145. ［13］VAN DEN BOOGAARD E, VISSENBERG R, LAND J A, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review ［J］. Human Reproduction Update, 2011, 17 (5): 605-619. ［14］SMITH A, ECCLES-SMITH J, D'EMDEN M，et al. Thyroid disorders in pregnancy and postpartum ［J］. Australian Prescriber,2017，40 (6):214-219. ［15］KRASSAS G E, POPPE K, GLINOER D. Thyroid function and human reproductive health ［J］. Endocrine Reviews, 2010, 31 (5): 702-755. ［16］SEUNGDAMRONG A. The impact and management of subclinical hypothyroidism for improving reproductive outcomes such as fertility and miscarriage ［J］. Seminars in Reproductive Medicine, 2016, 34 (6): 331-336. ［17］Li Q, Wang B, Mu K, et al. The pathogenesis of thyroid autoimmune diseases:New T lymphocytes-Cytokines circuits beyond the Th1-Th2 paradigm ［J］. Journal of Cellular Physiology, 2018,234 (3):2204-2216. ［18］NAKAMURA H, USA T, MOTOMURA M, et al. Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders ［J］. Journal of Endocrinological Investigation, 2008, 31 (10): 861-865. ［19］KIM N Y, CHO H J, KIM H Y, et al. Thyroid autoimmunity and its association with cellular and humoral immunity in women with reproductive failures ［J］. American Journal of Reproductive Immunology, 2011, 65 (1): 78-87. ［20］TIERNEY K, DELPACHITRA P, GROSSMANN M, et al. Thyroid function and autoantibody status among women who spontaneously deliver under 35 weeks of gestation ［J］. Clinical Endocrinology, 2009, 71 (6): 892-895. ［21］ALEXANDER E K. Autoimmunity: thyroid autoantibodies and pregnancy risk ［J］. Nature Reviews Endocrinology, 2011, 7 (9): 501-502. ［22］MEENA Monika, CHOPRA S, JAIN V, et al. The effect of anti-thyroid peroxidase antibodies on pregnancy outcomes in euthyroid women ［J］. Journal of Clinical and Diagnostic Research: JCDR, 2016, 10 (9): QC04-QC07.

相似文献/References:

[1]吴池华,刘锦平.妊娠哺乳期乳腺癌的临床问题[J].中国计划生育和妇产科,2009,(05):0.
　WU Chi-hua,LIU Jin-ping The department of breast surgery,The academy of science · Sichuan provincal peoples hospital.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(10):0.
[2]夏晓梦,方小玲.妊娠期宫颈细胞学与阴道镜检查的特征与处理[J].中国计划生育和妇产科,2013,(01):0.
　XIA Xiao-meng,FANG Xiao-ling*.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(10):0.
[3]李光辉,孔丽君,张为远,等.子痫前期的脂代谢[J].中国计划生育和妇产科,2014,(01):0.
　LI Guang-hui,KONG Li-jun,ZHANG Wei-yuan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(10):0.
[4]陈彧,冯欣,杨华,等.妊娠期疾病常用中成药使用原则及禁忌[J].中国计划生育和妇产科,2015,(02):0.
[5]周慧梅,李威,朱兰,等.妊娠期急性阑尾炎诊治进展[J].中国计划生育和妇产科,2015,(02):0.
[6]崔淑娟,马艳芬.妊娠期心理压力与自然流产的关系[J].中国计划生育和妇产科,2015,(03):0.
　CUI Shu-juan,MA Yan-fen,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(10):0.
[7]何书励,马良坤,刘俊涛,等.早产和营养[J].中国计划生育和妇产科,2015,(05):0.
[8]杨孜,张为远.如何理解和践行中国妊娠期高血压疾病诊治指南(2015)[J].中国计划生育和妇产科,2016,(04):0.
[9]李力,顾焱,陈建坤,等.妊娠期高血压疾病与产后出血[J].中国计划生育和妇产科,2016,(04):0.
[10]付婷,侯顺玉.妊娠期暴发性1型糖尿病发生死胎1例及相关文献复习[J].中国计划生育和妇产科,2016,(06):0.
[11]沈小波,李盛,陈伟,等.妊娠早期甲状腺过氧化物酶抗体水平对妊娠期妇女及胎儿甲状腺功能、妊娠结局的影响[J].中国计划生育和妇产科,2019,(2):70.
　SHEN Xiao-bo,LI Sheng,CHEN Wei,et al.Influence of thyroid peroxidase antibody levels in early pregnancy on pregnancy outcome and pregnant women’s and fetal thyroid function[J].Chinese Journal of Family Planning & Gynecotokology,2019,(10):70.

备注/Memo

备注/Memo:
苏州市吴江区第一人民医院院级项目（项目编号：201720）
更新日期/Last Update: 2019-10-25